Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Cytosine Ribonucleoside
2. Cytosine Riboside
3. Ribonucleoside, Cytosine
4. Riboside, Cytosine
1. 65-46-3
2. Cytosine Riboside
3. 1-beta-d-ribofuranosylcytosine
4. 4-amino-1-beta-d-ribofuranosyl-2(1h)-pyrimidinone
5. 1beta-ribofuranosylcytosine
6. Cytidin
7. Beta-d-ribofuranoside, Cytosine-1
8. 1-beta-ribofuranosylcytosine
9. 1beta-d-ribofuranosylcytosine
10. 4-amino-1beta-d-ribofuranosyl-2(1h)-pyrimidinone
11. Zytidin
12. Cytosine, 1-beta-d-ribofuranosyl-
13. 1beta-2'-ribofuranosylcytosine, D-
14. Nsc 20258
15. Cytosine-1beta-d-ribofuranoside
16. Cyd
17. Chebi:17562
18. 2(1h)-pyrimidinone, 4-amino-1-beta-d-ribofuranosyl-
19. 2(1h)-pyrimidinone, 4-amino-1beta-d-ribofuranosyl-
20. 4-amino-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
21. 5csz8459rp
22. 4-amino-1-beta-d-ribofuranosylpyrimidin-2(1h)-one
23. Nsc-20258
24. 4-amino-1-((2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1h)-one
25. 4-amino-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one
26. Mfcd00006545
27. 4-amino-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one
28. Smr000058243
29. 1.beta.-ribofuranosylcytosine
30. Einecs 200-610-9
31. 1.beta.-d-ribofuranosylcytosine
32. Unii-5csz8459rp
33. Beta-cytidine
34. .beta.-d-ribofuranoside, Cytosine-1
35. 3h-cytidine
36. Cytosine, 1-.beta.-d-ribofuranosyl-
37. Posilent (tn)
38. Ctn
39. Beta.-d-ribo-c
40. Cytidine, 99%
41. Cytosine B-d-riboside
42. Cytidine [inci]
43. 1-b-d-ribosyl-cytosine
44. Cytidine [mi]
45. Cytosine-beta-d-riboside
46. Cp-c
47. 4-amino-1.beta.-d-ribofuranosyl-2(1h)-pyrimidinone
48. Cytidine [mart.]
49. Bmse000190
50. Bmse000969
51. Bmse001020
52. Cytidine [who-dd]
53. Epitope Id:141494
54. 2(1h)-pyrimidinone, 4-amino-1-.beta.-d-ribofuranosyl-
55. Schembl7179
56. 1-b-d-ribofuranosylcytosine
57. Cytosine-1b-d-ribofuranoside
58. Beta-d-ribofuranosyl-cytidine
59. Mls000049947
60. Mls002207040
61. 1-beta-d-ribosyl- (6ci)
62. 1-beta-delta-ribosyl-cytosine
63. Chembl95606
64. Cytosine-1-b-d-ribofuranoside
65. Gtpl4728
66. 1-beta-d-ribofuranosyl-cytosine
67. Cytosine-1b-delta-ribofuranoside
68. 1-beta-d-ribofuranoside Cytosine
69. 1beta-delta-ribofuranosylcytosine
70. Dtxsid60891552
71. 1-beta-delta-ribofuranosylcytosine
72. Cytidine, >=99.0% (hplc)
73. Cytosine-1beta-delta-ribofuranoside
74. 1-beta-delta-ribofuranosyl-cytosine
75. Hy-b0158
76. Zinc2583632
77. Mmv638723
78. S2053
79. Akos015888568
80. Am83932
81. Ccg-266896
82. Cs-1989
83. Db02097
84. Sri-2352_17
85. Ncgc00093356-08
86. Ncgc00142483-01
87. Ncgc00142483-09
88. As-12696
89. Db-029614
90. 65c463
91. C-9850
92. C00475
93. D07769
94. 1-(beta-d-ribofuranosyl)-4-aminopyrimidin-2-one
95. 4-amino-1-b-d-ribofuranosyl-2(1h)-pyrimidinone
96. Q422538
97. J-700167
98. Brd-k71847383-001-12-5
99. 4-amino-1-.beta.-d-ribofuranosyl-2-(1h)-pyrimidinone
100. 4-amino-1-beta-delta-ribofuranosyl-2(1h)-pyrimidinone
101. F0348-2240
102. 1-(b-d-ribofuranosyl)-2-oxo-4-amino-1,2-dihydro-1,3-diazine
103. 6d2dc474-dd76-4081-8b34-10605c218f49
104. 1-(b-delta-ribofuranosyl)-2-oxo-4-amino-1,2-dihydro-1,3-diazine
105. 1-(beta-d-ribofuranosyl)-2-oxo-4-amino-1,2-dihydro-1,3-diazine
106. Cytidine, Bioreagent, Suitable For Cell Culture, Powder, >=99%
| Molecular Weight | 243.22 g/mol |
|---|---|
| Molecular Formula | C9H13N3O5 |
| XLogP3 | -2.1 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 2 |
| Exact Mass | 243.08552052 g/mol |
| Monoisotopic Mass | 243.08552052 g/mol |
| Topological Polar Surface Area | 129 Ų |
| Heavy Atom Count | 17 |
| Formal Charge | 0 |
| Complexity | 383 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
Click Us!
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37773
Submission : 2022-12-23
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39614
Submission : 2024-03-20
Status : Active
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
APIs
Reply
18 Jun 2022
Reply
22 Jun 2017
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
ANALYTICAL
Analytical Methods
ABOUT THIS PAGE
72
PharmaCompass offers a list of Cytidine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cytidine manufacturer or Cytidine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cytidine manufacturer or Cytidine supplier.
PharmaCompass also assists you with knowing the Cytidine API Price utilized in the formulation of products. Cytidine API Price is not always fixed or binding as the Cytidine Price is obtained through a variety of data sources. The Cytidine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cytidine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cytidine, including repackagers and relabelers. The FDA regulates Cytidine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cytidine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cytidine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cytidine supplier is an individual or a company that provides Cytidine active pharmaceutical ingredient (API) or Cytidine finished formulations upon request. The Cytidine suppliers may include Cytidine API manufacturers, exporters, distributors and traders.
click here to find a list of Cytidine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cytidine DMF (Drug Master File) is a document detailing the whole manufacturing process of Cytidine active pharmaceutical ingredient (API) in detail. Different forms of Cytidine DMFs exist exist since differing nations have different regulations, such as Cytidine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cytidine DMF submitted to regulatory agencies in the US is known as a USDMF. Cytidine USDMF includes data on Cytidine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cytidine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cytidine suppliers with USDMF on PharmaCompass.
Cytidine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cytidine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cytidine GMP manufacturer or Cytidine GMP API supplier for your needs.
A Cytidine CoA (Certificate of Analysis) is a formal document that attests to Cytidine's compliance with Cytidine specifications and serves as a tool for batch-level quality control.
Cytidine CoA mostly includes findings from lab analyses of a specific batch. For each Cytidine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cytidine may be tested according to a variety of international standards, such as European Pharmacopoeia (Cytidine EP), Cytidine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cytidine USP).
Comment (6)
